Mental Health Center, West China Hospital, Sichuan University, Chengdu, China.
Am J Drug Alcohol Abuse. 2009;35(6):408-11. doi: 10.3109/00952990903377146.
Efforts toward researching effective and safe therapies for the treatment of drug addiction and acute heroin withdrawal syndrome remain important objectives in the field of drug addiction. Traditional Chinese medicine (TCM) is viewed as a potential approach to the treatment of drug addiction, and especially to opiate addiction.
The objective is to investigate the efficacy and safety of Fu-Yuan Pellet (FYP), a Chinese traditional medicine formula, for the treatment of acute heroin withdrawal syndrome.
A multicenter, randomized, double-blind, double-dummy, and positive-controlled trial was conducted at 3 drug abuse treatment centers in China. Patients (n = 225) who met a diagnosis of opiate dependence based on DSM IV classification were recruited for this study, ranging in age from 18 to 55 years. Inclusion criteria included a heroin-positive urinalysis, as measured between 8 to 36 hours from last use of heroin, and total withdrawal syndrome scores above 50 before treatment (actual range 65-140). These patients were treated with either FYP or lofexidine in a fixed schedule of doses for 10 days. The total withdrawal syndrome scores and the daily reduction rate were used to measure the effect of FYP vs. lofexidine.
Both treatments significantly reduced withdrawal symptoms by day 3, but there was no significant difference overall between lofexidine and FYP in efficacy or safety.
This clinical trial has shown that FYP is effective in the treatment of moderate-to-severe acute heroin withdrawal and has few adverse effects compared to lofexidine. Further study is warranted to determine whether FYP is similar to lofexidine in its potential for reducing stress induced opiate relapse.
研究治疗药物成瘾和急性海洛因戒断综合征的有效且安全的疗法仍然是成瘾领域的重要目标。传统中药(TCM)被视为治疗药物成瘾的一种潜在方法,特别是阿片类药物成瘾。
本研究旨在探讨福元丸(FYP)治疗急性海洛因戒断综合征的疗效和安全性。
在中国 3 家药物滥用治疗中心进行了一项多中心、随机、双盲、双模拟、阳性对照试验。符合 DSM-IV 分类的阿片类药物依赖诊断的患者(n=225),年龄在 18 至 55 岁之间,入组本研究。纳入标准包括:尿吗啡检测阳性,距最后一次使用海洛因 8 至 36 小时;治疗前的总戒断综合征评分超过 50 分(实际范围为 65-140 分)。这些患者以固定剂量方案接受 FYP 或可乐定治疗,疗程为 10 天。使用总戒断综合征评分和每日降低率来衡量 FYP 与可乐定的疗效。
两种治疗方法均在第 3 天显著减轻戒断症状,但可乐定与 FYP 在疗效或安全性方面总体无显著差异。
本临床试验表明,FYP 治疗中重度急性海洛因戒断症状有效,与可乐定相比,不良反应较少。需要进一步研究以确定 FYP 是否与可乐定一样具有降低应激诱导的阿片类药物复吸的潜力。